Barbara Lavery

Chief Program Officer

Barbara joined Alliance for Cancer Gene Therapy (ACGT) as Chief Program Officer in November 2019 having served as a consultant to the organization since January 2019. Most recently, she was SVP Business Development at Global Genes, a rare disease non-profit, having previously served as Board Chair. Prior to Global Genes, Barbara was President & CEO of Zoomedia, a leading communications agency for the life sciences, building an extensive network of clients across the corporate and non-profit sectors until the company was acquired in 2014. At ACGT, Barbara’s principal role is to lead the organization’s Academic Research Program and Biotechnology Investment Program while continuing to build awareness of ACGT with all cancer cell and gene therapy stakeholders.

Return to Leadership